NCT06723717View on ClinicalTrials.gov

Efficacy of Daily IV Administration of Dornase Alfa Up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence At 6 Months

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Ruptured Aneurysm of Intracranial ArterySAH (Subarachnoid Hemorrhage)Delayed Cerebral Ischemia
Interventions
DRUG

Daily infusion of dornase alfa

Daily infusion of dornase alfa at a dose of 125 microg/kg as an intravenous bolus until day 14 after SAH

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK